Literature DB >> 23123915

Comparison of hematologic measurements between local and central laboratories: data from the BABY HUG trial.

Ram Kalpatthi1, Bruce Thompson, Ming Lu, Winfred C Wang, Niren Patel, Abdullah Kutlar, Thomas Howard, Lori Luchtman-Jones, Scott T Miller.   

Abstract

OBJECTIVES: To investigate the concordance of blood count indices measured locally and at a central laboratory. DESIGN AND METHODS: In a multi-center clinical trial of hydroxyurea therapy in infants with sickle cell anemia (BABY HUG), the concordance between blood count indices measured locally and at a central laboratory was investigated.
RESULTS: Local laboratory measurements of neutrophil and monocyte counts were significantly higher (44% and 37%, respectively) compared to the central measurements (p<0.0001), and mean corpuscular volume (MCV) was higher centrally.
CONCLUSION: Overnight shipping with processing delay causes spurious reductions in absolute neutrophil count (ANC) and absolute monocyte count (AMC) that may result in incorrect monitoring decisions in multicenter clinical trials.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123915      PMCID: PMC4550480          DOI: 10.1016/j.clinbiochem.2012.10.032

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

1.  Specimen collection, storage, and transmission to the laboratory for hematological tests.

Authors:  N Tatsumi; S Miwa; S M Lewis
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Shipment impairs lymphocyte proliferative responses to microbial antigens.

Authors:  R A Betensky; E Connick; J Devers; A L Landay; M Nokta; S Plaeger; H Rosenblatt; J L Schmitz; F Valentine; D Wara; A Weinberg; H M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

3.  [Effect of time factors and transportation on circulating neutrophil counts in patients with chemotherapy-induced neutropenia].

Authors:  C Bayle; M Bensmaine; M Henry-Amar
Journal:  Pathol Biol (Paris)       Date:  1992-01

4.  Biorepository and biospecimen science: a new focus for CEBP.

Authors:  Jimmie B Vaught
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-09       Impact factor: 4.254

5.  Guidance for storing blood samples in laboratories performing complete blood count with differential.

Authors:  E Cornet; C Behier; X Troussard
Journal:  Int J Lab Hematol       Date:  2012-07-24       Impact factor: 2.877

6.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Authors:  Winfred C Wang; Russell E Ware; Scott T Miller; Rathi V Iyer; James F Casella; Caterina P Minniti; Sohail Rana; Courtney D Thornburg; Zora R Rogers; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada A Sarnaik; Thomas H Howard; Lynn W Wynn; Abdullah Kutlar; F Daniel Armstrong; Beatrice A Files; Jonathan C Goldsmith; Myron A Waclawiw; Xiangke Huang; Bruce W Thompson
Journal:  Lancet       Date:  2011-05-14       Impact factor: 79.321

7.  Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability.

Authors:  Alan R Kristal; Irena B King; Demetrius Albanes; Michael N Pollak; Frank Z Stanzyk; Regina M Santella; Ashraful Hoque
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

8.  Effect of shipment, storage, anticoagulant, and cell separation on lymphocyte proliferation assays for human immunodeficiency virus-infected patients.

Authors:  A Weinberg; R A Betensky; L Zhang; G Ray
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

9.  The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.

Authors:  Bruce W Thompson; Scott T Miller; Zora R Rogers; Renee C Rees; Russell E Ware; Myron A Waclawiw; Rathi V Iyer; James F Casella; Lori Luchtman-Jones; Sohail Rana; Courtney D Thornburg; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada Sarnaik; Thomas H Howard; Lori Luck; Winfred C Wang
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

10.  Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function.

Authors:  Walter C Olson; Mark E Smolkin; Erin M Farris; Robyn J Fink; Andrea R Czarkowski; Jonathan H Fink; Kimberly A Chianese-Bullock; Craig L Slingluff
Journal:  J Transl Med       Date:  2011-03-08       Impact factor: 5.531

  10 in total
  5 in total

Review 1.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

Review 2.  Interventions for chronic kidney disease in people with sickle cell disease.

Authors:  Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2017-07-03

Review 3.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Angela E Rankine-Mullings; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2022-09-01

Review 4.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Sarah J Nevitt; Ashley P Jones; Jo Howard
Journal:  Cochrane Database Syst Rev       Date:  2017-04-20

5.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Catherine Kimber; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2020-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.